Open Tender for Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl in GORAKHPUR, UTTAR PRADESH

The eligibility requirements include being a registered entity capable of supplying pharmaceutical products, possessing relevant experience in drug provision, and complying with national regulations governing pharmaceuticals. Participants must ensure they meet these standards for successful entry into the bidding process.

To ensure a complete submission, bidders must include essential documents such as registration certificates, technical specifications of the products offered, financial bid documentation, and proof of compliance with quality standards. These documents must be submitted electronically as specified.

The EMD for this tender is set at ₹884,149. This deposit is a security measure to ensure the commitment of bidders to the procurement process. Participants must submit this deposit as part of their bid to be considered eligible.

All bidders must comply with rigorous quality standards defined by national and international regulatory bodies. This includes providing evidence of quality control measures, certifications from recognized laboratories, and scientific validations of the pharmaceutical products offered.

The evaluation process involves a multi-faceted approach where both technical and financial bids are assessed. Notably, the compliance with eligibility criteria, the robustness of technical documents, and cost efficiency in financial proposals are considered to ensure the most suitable suppliers are selected.

Yes, the tender encourages participation from MSEs. Specific incentives are available to support these enterprises in contributing to public procurement efforts, facilitating a diverse range of bidders in the drug supply market.

Bidders must detail the testing criteria that their products meet, including safety, efficacy, stability testing, and compliance with pharmacopoeial standards. Documentation supporting these claims must be provided during the bid submission.

Proposals must be submitted electronically through the designated procurement portal specified in the tender documentation. Bidders should ensure they follow all submission guidelines outlined to validate their bids.

While specific dates may vary, bidders should refer to the tender documents for detailed timelines related to bid submission, opening dates, and evaluation periods. Ensuring adherence to these timelines is crucial for successful submission.

The price evaluation is based on the comprehensive financial proposal, which incorporates the overall cost-effectiveness of the bid. Factors such as discounts, cost of delivery, and quality guarantees may influence the final pricing considerations within the evaluation.

Bidders must demonstrate compliance with all associated regulatory and quality assurance standards pertaining to pharmaceutical supply. Relevant certifications and qualifications must be submitted to prove adherence to these compliance requirements.

Startups participating in this procurement process may benefit from incentives and support mechanisms in place to stimulate engagement. This could include financial considerations, training opportunities, or assistance in navigating the procurement landscape.

Bidders must ensure compliance with prevailing local content and procurement policies, specifically any mandates encouraging sourcing from local manufacturers and service providers, contributing to the broader economic agenda.

Bidders will be notified of the results through designated communication channels outlined in the tender documentation. Transparency in the evaluation and selection process is a key priority, ensuring all parties understand the outcomes of the tender.